Please login to the form below

Not currently logged in
Email:
Password:

Chemia

This page shows the latest Chemia news and features for those working in and with pharma, biotech and healthcare.

Creston Health rebrands under Health Unlimited banner

Creston Health rebrands under Health Unlimited banner

However, Health Unlimited's international network Chemia will remain unchanged.  . Debra Jux, associate director, procurement – business unit lead at Astellas Pharma Europe, said Health Unlimited's new approach was one of

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Chemia appoints network manager Chemia appoints network manager

    Ellie Duncanson-Hunter joins from PMGroup where she was events director. Chemia - Creston Health's global network of specialist healthcare consultancies - has appointed Ellie Duncanson-Hunter as network manager. ... Chemia is an integrated network of

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics